期刊文献+

甲状腺癌的基因治疗 被引量:1

Gene therapy for thyroid cancer
下载PDF
导出
摘要 甲状腺癌的基因治疗包括免疫基因疗法,自杀基因疗法,抑癌基因疗法,NIS基因介导的131I治疗,反义基因治疗等,具有广阔的前景,但应用于临床还有许多的问题需要解决。 Gene therapy for thyroid cancer include immunotherapy,suicide gene therapy,tumor suppressor replacement,131 I therapy by sodium/iodide symporter and antisense therapy and so on.Gene therapy has wide perspectives,but there are many problems need to be solved for clinical application.
作者 程刚
出处 《国外医学(放射医学核医学分册)》 2002年第6期253-256,共4页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
  • 相关文献

参考文献23

  • 1Zhang R, Baunoch D, De Groot LJ. Genetic immunotherapy for medullary thyroid carcinoma: destruction of tumors in mice by in vivo delivery of adenoviral vector transducing the murineinterleukin-2 gene[J]. Thyroid, 1998, 8(12):1137-1146.
  • 2Zhang R, Straus FH, De Groot LJ. Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: dissemination and cytotoxicity studies in a rat tumor model[J]. Endocrinology, 1999, 140(5): 2152-2158.
  • 3Zhang R, De Groot LJ. Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model[J]. Clin Endocrinol (Oxt), 2000, 52(6): 687-694.
  • 4Yamazaki M, Zhang R, Straus FH, et al. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12[J]. Gene Ther, 2002, 9(1): 64-74.
  • 5Soler MN, Bobe P, Benihoud K, et al. Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase Ⅱ DNA injection[J]. J Gene Med, 2000, 2(5): 344-352.
  • 6Nishihara E, Nagayama Y, Mawatari F, et al. Retrovirusmediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo[J]. Endocrinology, 1997, 138(11): 4577-4583.
  • 7Braiden V, Nagayama Y, Iitaka M, et al. Retroviras-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter[J]. Endocrinology, 1998, 139(9): 3996-3999.
  • 8Nagayama Y, Nishihara E, Iitaka M, et al. Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system[J]. Cancer Res, 1999, 59(13): 3049-3052.
  • 9Shimura H, Suzuki H, Miyazaki A, et al. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells[J]. Cancer Res, 2001, 61(9): 3640-3646.
  • 10Kitazono M, Chuman Y, Aikou T, et al. Adenovirus HSVTK construct with thyroid-specific promoter: Enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway[J]. Int J Cancer, 2002, 99(3): 453-459.

同被引文献22

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部